Liberal transfusion may improve outcomes in myocardial infarction and anemia
1. In this secondary analysis of the MINT trial, 30-day risks for the composite outcome of death and recurrent myocardial ...
1. In this secondary analysis of the MINT trial, 30-day risks for the composite outcome of death and recurrent myocardial ...
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. This retrospective cohort study demonstrated that for a given blood oxygen hemoglobin saturation, Black, Asian, and Hispanic patients in ...
1. This trial demonstrated noninferiority of daprodustat to darbepoetin alfa in the treatment of anemia in patients with chronic kidney ...
1. Betibeglogene autotemcel (beti-cel) gene therapy resulted in sustained hemoglobin A with a T87Q amino acid substitution (HbAT87Q) in non-β0/β0 ...
1. Sutimlimab was shown to stop hemolysis, improve hemoglobin levels, and reduce patient fatigue in patients with cold agglutinin disease. ...
1. Children with sickle cell disease who received the maximum tolerated dose of hydroxyurea had higher concentrations of hemoglobin and ...
1. In this secondary analysis of data from the CANTOS trial in 2017, canakinumab significantly reduced the incidence of anemia ...
1. Maternal hemoglobin levels were measured at 2 antenatal visits and delivery, while their infants were followed 1 year later ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.